The silent PPARγ exon 6 CAC(His) → CAT(His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany

Experimental and Clinical Endocrinology and Diabetes

Volumn 108, Issue 5, 2000, Pages 341-346

  Koch, M ^a,b   Rett, K ^a   Maerker, E ^a   Volk, A ^a   Haist, K ^a   Deninger, M ^a   Rettig, A ^a   Renn, W ^a   Haring H U ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Labor Dr Wagner und Partner   (Germany)

Author keywords

Insulin resistance; Obesity; Peroxisome proliferator activated receptors; Plasma leptin; Type 2 diabetes

Indexed keywords

C PEPTIDE; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; CELL RECEPTOR;

ADIPOCYTE; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENETIC ASSOCIATION; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HETEROZYGOTE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NEGATIVE FEEDBACK; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RELATIVE; SILENT GENE; ADOLESCENT; BLOOD; BODY MASS; GENETIC POLYMORPHISM; GENETICS; GERMANY; MIDDLE AGED; MUTATION; PHENOTYPE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; EXONS; FEMALE; GERMANY; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0033626340     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-8126     Document Type: Article

References (25)

1. Auboeuf D, Rieusset J, Fajas L et al.: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 48: 1319-1327, 1997
2. Bougoulia M, Tzotzas T, El'thymiou H, Koliakos G, Konstantinidis T, Triantos A, Krassas GE: Leptin concentrations during oral glucose tolerance test (OGTT) in obese and normal weight women. Int J Obes Relat Metab Disord 23: 625-628, 1999
3. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L. Kuusisto J, Laakso M, Fujimoto W, Auwerx J: A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature genetics 20: 284-287, 1998
4. De Fronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237: E214-423, 1979
5. De Vos P, Lefebvre AM, Miller SG, Guerre-Millo M, Wong K, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J: Thiazolidinediones repress ob gene expression via activation of PPARγ. J. Clin. Invest. 98: 1004-1009, 1996
6. Ek J, Urhammer SA, Sorensen TI, Andersen T, Auwerx J, Pedersen O: Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activaledreceptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 42: 892-895, 1999
7. Eriksson J, Franssila Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 321: 337-343, 1989
8. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, Najib J, Laville M, Fruchart JC, Deeb S, Puig-Vidal A, Flier J, Briggs MR, Staels B, Vidal H, Auwerx J: The human PPARg gene: organization, promoter analysis, and expression. J. Biol. Chem. 272: 18779-18789, 1997
9. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83: 803-812, 1995
10. Friedman JM: Role of leptin and its receptors in the control of body weight. In: Blum WF, Kiess W, Rascher W, (Eds.). Leptin - The voice of adipose tissue. J.A. Barth Verlag, Edition J&J, 3-22, 1997
11. Kallen CB, Lazar MA: Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 93: 5793-5796, 1996
12. Kellerer M, Koch M, Kroder G, Häring HU: Crosstalk of leptin and insulin signaling chains: pivotal role of phosphatidylinositol (PI3)-kinase. In: Blum WF, Kiess W, Rascher W, (Eds.). Leptin - The voice of adipose tissue. J.A. Barth Verlag, Edition J&J, 58-66, 1997
13. 12Ala is prevalent in offspring of type 2 diabetes patients and is associated to increased insulin sensitivity in a subgroup of obese individuals. Diabetologia 42: 758-762, 1999
14. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a higher affinity ligand for peroxisome proliferator-activated receptor γ. J. Biol. Chem. 270: 12953-12956, 1995
15. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340: 925-929, 1992
16. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, Deeb S, Auwerx J, Amouyel P: A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet 7: 435-440, 1998
17. Reaven GM: Pathophysiology of insulin resistance in human disease. Physiol. Rev. 75: 473-486, 1995
18. Ristow M, Müller-Wieland D, Pfeiffer A, Krone W, Kahn CR: Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med 339(14): 953-959, 1998
19. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J: PPARα and PPARγ activators direct a tissue-specific transcriptional response via PPRE in the lipoprotein lipase gene. EMBO J. 15: 5336-5348, 1996
20. Schoonjans K, Watanabe M, Suzuki H, Mahfoudi A, Krey G, Wahli W, Grimaldi P, Staels B, Yamamoto T, Auwerx J: Induction of the acyl-coenzyme A synthase gene by fibrates and fatty acids is mediated by peroxisome proliferator response element in the C promoter. J. Biol. Chem. 270: 19269-19276, 1995
21. Spiegelman BM: PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47: 507-514, 1998
22. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM: PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxikinase gene. Mol. Cell. Biol. 15: 351-357, 1995
23. Volund A, Polonsky KS, Bergman RN: Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes 36: 1195-1202, 1987
24. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, Shuldiner AR: Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians: identification of a Pro12Ala PPARγ2 missense mutation. Biochem Biophys Res Commun 241: 270-274, 1998
25. Zhang B, Graziano MP, Doebber TW, Leibowitz MD, White-Carrington S, Szalkowski DM, Hey PT, Wu M, Cullinan CA, Bailey P, Collmann B, Frederich R, Flier JS, Strader CD, Smith RG: Down-regulation of the expression of the obese gene by antidiabetic thiazolidinediones in Zucker diabetic fatty rats and db/db mice. J. Biol. Chem. 271: 9455-9459, 1996